Aruni Ghose, Co-Founder and Chief Medical Officer of OncoFlow, posted the following on LinkedIn:
“It was more than a dream to be welcomed by one of India’s most sought-after radiation oncologists—an institution in herself—Dr. Swarupa Mitra at Fortis Memorial Research Institute – India.
What a pleasure to have worked together on:
- 177Lu-PSMA-617 in the Indian Prostate Cancer Setting (The Lancet Group)
- Cervical Cancer Vaccination in the Indian setting (Society of Gynecologic Oncology)
- Innovation in HPV Prevention Strategies (ecancer)
Delighted to be introduced to the whole team physically and virtually for the OncoFlow Platform Clinical Adoption and Implementation at the Fortis Cancer Institute and India-wide Fortis Group. Exciting times ahead!”
